Elevating hope through breast cancer innovationA breakthrough in diagnostic testing is providing hope for patients like Enisa, who is receiving new targeted treatment to combat HER2-low breast cancer.November 19, 2025
Cervical cancer: it only ends with all of usAt Roche, we are committed to eliminating cervical cancer, and it all starts with attendance at screening appointments. November 12, 2025
Now you see me, now you don’t: How can we change the trajectory for vision loss?With millions of people worldwide living with retinal conditions, scientists at Roche are committed to preventing, and even reversing, vision loss.May 06, 2025
PodcastA conversation on why biomarker testing matters in lung cancerGuests Lorraine Tyler, an advocate and lung cancer patient, and Mark Brooke, CEO of Lung Foundation Australia, explore the importance of biomarker testing in lung cancer. November 10, 2023
Biomarker testing: Unlocking the unknown about lung cancerKnowing your cancer’s biomarkers can help inform your treatment decisions. Learn more about the importance of biomarker testing in lung cancerJuly 28, 2023
Biomarker testing: Why is it so important in lung cancer care?Discover how knowing your cancer’s biomarkers can help inform your treatment decisions.July 28, 2023
Rewriting the book on immunotherapyLearn how biomarkers take the stage in helping doctors diagnose cancer.November 03, 2021
The NT-proBNP storyBiomarkers play a crucial role in Roche’s commitment to personalised healthcare. To find them, we rely on the promising research of our external partners.November 03, 2021
The measure of youExplore how digital biomarkers are changing the way we understand health.November 03, 2021
Biomarkers: Changing the way Alzheimer’s disease is diagnosedBiomarkers play a crucial role in medical research; find out what they are and how they're used in Alzheimer's disease.July 20, 2020